Business
MedX Health Corp. Announces Share Issuance Pursuant To Debt Settlement Agreements And Also Grant Of Stock Options
TSX Venture Symbol: MDX TORONTO , July 19, 2013 /CNW/ - MedX Health Corp. ("MDX" or ...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\nTSX Venture Symbol: MDX\n\n\nTORONTO, July 19, 2013 /CNW/ - MedX Health Corp. (\"MDX\" or the\n \"Company\", TSX - MDX) announces that further to the notification given\n in the Press Release issued on July 4, 2013, it has issued 3,620,780\n Units, comprising a total of 3,620,780 common shares at a deemed value\n of $0.10 per share and 1,810,390 share purchase warrants, to settle\n outstanding debt of $362,078.16. Each share purchase warrant entitles\n the holder to purchase one (1) fully paid non-assessable common share\n from the treasury of MedX during the period commencing on the date of\n issue and expiring on December 31, 2015 (the \"Expiration Date\"), at an\n exercise price of $0.20 if exercised before January 1, 2015, and at an\n exercise price of $0.30 if exercised after December 31, 2014 and prior\n to the Expiration Date.  The shares and securities underlying the share\n purchase warrants are subject to a restricted hold period of four\n months and one day from July 10, 2013.\n\n\nFollowing issuance of these shares, the Company will have 44,966,291\n common shares outstanding on an undiluted basis.\n\n\nThe Company also announces that the Board of Directors has approved the\n grant of 400,000 incentive stock options to a senior officer; the\n options are exercisable at $0.10 per share, vesting immediately and are\n valid for a period of five years expiring on July 15, 2018, and\n otherwise subject to the terms of the Company's Stock Option Plan.\n\n\nAbout MedX Health Corp.\nMedX is a twelve (12) year old Canadian company, headquartered in\n Mississauga, Ontario (Toronto), and is a global leader in the design,\n manufacturing and distribution of quality low level laser and light\n therapy technologies for use in numerous medical settings, including\n rehab/chiropractic, dental, wound care, and veterinary medicine,\n providing patients with drug free and non-invasive treatment of tissue\n damage and pain. MedX laser and light products are FDA approved, Health\n Canada cleared, and CE Mark approved for use in North America as well\n as the European Union. MedX Health acquired the worldwide assets of\n SIMSYS™ and MoleMate™ in June, 2011. For a complete profile of MedX\n Health Corp. and its products visit www.medxhealth.com.\n\n\nAbout SIMSYS™ and MoleMate™ Skin Cancer Imaging\nSI...